Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've seen a Wegovy GIF online, it almost certainly shows a pre-filled injection pen being clicked into the skin, a slow-motion needle mechanism, or an animated diagram of appetite signals in the brain. These short clips do capture something real about how semaglutide is administered, but they leave out a lot of the clinical picture. Wegovy (semaglutide) is a once-weekly subcutaneous injection licensed in the UK for weight management in adults with a BMI of 30 or above, or from 27 with a weight-related health condition. It is a prescription-only medicine, which means a qualified prescriber must assess your suitability before any treatment can begin, regardless of what any animation makes it look like.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The overwhelming majority of Wegovy GIFs circulating on health forums and social media show the pen's injection sequence. You'll see the cap removed, the pen pressed against a fold of skin (usually an abdomen or thigh) and then the click that releases the needle and delivers the dose. That mechanical sequence is accurate. The Wegovy pen is an auto-injector: you press it flat against the skin, click once, and hold it in place for a few seconds while the medicine is delivered. The needle retracts automatically when you lift the pen away.
Some GIFs animate the pharmacology rather than the hardware: a stylised rendering of semaglutide binding to GLP-1 receptors in the gut and brain, with arrows representing reduced hunger signals. Those diagrams reflect real biology. Semaglutide acts as a GLP-1 receptor agonist, mimicking the gut hormone released after eating, which helps slow the passage of food through the stomach and reduces the drive to eat, as explained in the NHS's patient guide to semaglutide. What no GIF can convey is how variable the individual response is, or which patients the medicine is and isn't right for.
There's a second category of animations showing rotating dose ladders: 0.25mg, 0.5mg, 1.0mg, 1.7mg, 2.4mg, and now a 7.2mg option since the MHRA approved a dedicated single-dose 7.2mg pen in April 2026. These are factually structured, but they can give the impression that dose progression is automatic and self-managed. It isn't. A prescriber reviews your progress, tolerance and weight response before any increase, and if you want to understand exactly what starting out looks like, the guide to Wegovy 1 walks through the earliest stage of treatment in detail.
The decision a clinician works through before prescribing Wegovy is genuinely complex, and no thirty-frame loop captures it. They're looking at your BMI, your medical history, any medicines you already take, your kidney and liver function, and whether you have conditions that put GLP-1 medicines off the table entirely, a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia, for instance, or a history of pancreatitis.
Side effects don't appear in GIFs either, and they're worth knowing about before you start. The most common ones are gastrointestinal: nausea, loose stools, constipation, reflux, belching. They tend to be most noticeable in the first week or two after a dose increase and often settle down, but some people find them persistent enough to pause or slow their titration, and the Wegovy 2 guide covers what to expect as you move into the next phase of dose increases. More serious but infrequent risks include acute pancreatitis, the MHRA Drug Safety Update from January 2026 flagged this for GLP-1 medicines and advises seeking urgent medical attention for severe stomach pain that spreads to the back. These are things to discuss before the first pen is unwrapped, not after.
If you're weighing up whether Wegovy is the right route for you, the Wegovy overview at nume covers the evidence, eligibility criteria and what the titration process looks like in practice. For detail on how the injection itself works, the step-by-step injection guide replaces any GIF with actual clinical instruction.
Wegovy pens are refrigerated, kept between 2°C and 8°C. A lot of people slot theirs into the fridge door next to everyday things, which is fine as long as the temperature stays stable and the pen is never frozen. If you need to travel or the pen has been out of the fridge, the Patient Information Leaflet spells out the exact room-temperature window permitted; stick to that rather than estimating from memory or from anything you've seen in a social clip.
The weekly injection routine matters more than most GIFs suggest. Choosing a consistent day and a consistent time lowers the chance of forgetting a dose, and rotating your injection site (abdomen, thigh, or upper arm, each in a slightly different spot from the previous week) reduces the local skin reactions that can build up if you inject the same patch repeatedly. None of that appears in a ten-second loop. The clinical background on semaglutide gives more context on how the medicine fits into a broader weight management plan.
Cost is another thing animations never mention. If you're comparing services and wondering what private Wegovy treatment involves financially, the Wegovy pricing guide sets out what a legitimate private prescription typically costs and what a single transparent price should include.
Wegovy is a prescription-only medicine in the UK. That means watching a GIF, reading a forum thread, or seeing a social media post doesn't get you any closer to a prescription, a qualified clinician has to assess you first. On the NHS, Wegovy is available through specialist weight management services under NICE guidance (TA875), but waiting lists are long in most areas. The private route through a regulated online pharmacy allows you to access treatment without a referral, subject to clinical suitability.
When you choose a private pharmacy, it's worth verifying it on the GPhC register before handing over any personal or payment details. The MHRA has warned publicly about fake weight-loss pens sold through social media, sellers offering these medicines without a genuine prescription or clinical assessment are a red flag, full stop.
At nume, every consultation is read and assessed the same day by a GPhC-registered Independent Prescriber, a real clinician, not automated software. If treatment is clinically appropriate, orders placed before midday are dispatched the same day and arrive the next working day by tracked DPD delivery. If you'd like to explore whether Wegovy is suitable for you, start your free consultation and speak to our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.